GB9924855D0 - Novel processes - Google Patents
Novel processesInfo
- Publication number
- GB9924855D0 GB9924855D0 GBGB9924855.1A GB9924855A GB9924855D0 GB 9924855 D0 GB9924855 D0 GB 9924855D0 GB 9924855 A GB9924855 A GB 9924855A GB 9924855 D0 GB9924855 D0 GB 9924855D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel processes
- novel
- processes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9924855.1A GB9924855D0 (en) | 1999-10-20 | 1999-10-20 | Novel processes |
| AU10379/01A AU1037901A (en) | 1999-10-20 | 2000-10-20 | Process for the preparation of paroxetine |
| PCT/GB2000/004060 WO2001029031A1 (en) | 1999-10-20 | 2000-10-20 | Process for the preparation of paroxetine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9924855.1A GB9924855D0 (en) | 1999-10-20 | 1999-10-20 | Novel processes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9924855D0 true GB9924855D0 (en) | 1999-12-22 |
Family
ID=10863080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9924855.1A Ceased GB9924855D0 (en) | 1999-10-20 | 1999-10-20 | Novel processes |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU1037901A (en) |
| GB (1) | GB9924855D0 (en) |
| WO (1) | WO2001029031A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9930577D0 (en) * | 1999-12-23 | 2000-02-16 | Smithkline Beecham Plc | Novel process |
| CN101460461B (en) * | 2006-04-03 | 2012-10-03 | 弗·哈夫曼-拉罗切有限公司 | Process for preparation of enantiomerically enriched cyclic beta-aryl or heteroaryl carboxylic acids |
| US7872022B2 (en) | 2006-04-03 | 2011-01-18 | Hoffmann-La Roche Inc. | Serotonin transporter (SERT) inhibitors for the treatment of depression and anxiety |
| CN101205211B (en) * | 2006-12-19 | 2011-12-14 | 北京德众万全药物技术开发有限公司 | Method for preparing hydrochloric paroxetine key intermediates |
| WO2010069793A1 (en) | 2008-12-16 | 2010-06-24 | F. Hoffmann-La Roche Ag | Process for the preparation of pyrollidine-3-carboxylic acids |
| CN108486171A (en) * | 2018-03-12 | 2018-09-04 | 江苏扬农化工股份有限公司 | A kind of preparation method of the first chrysanthemumic acid of d-trans |
| CN108486170A (en) * | 2018-03-12 | 2018-09-04 | 江苏扬农化工股份有限公司 | A kind of preparation method of d-trans dichlor chrysanthemic acid |
| CN115724831A (en) * | 2022-11-18 | 2023-03-03 | 上海陶术生物科技有限公司 | Preparation method and application of (3S, 4R) -piperidine compound |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| EP0223334B1 (en) * | 1985-08-10 | 1991-07-10 | Beecham Group Plc | Process for the preparation of aryl-piperidine carbinols |
| GB8520154D0 (en) * | 1985-08-10 | 1985-09-18 | Beecham Group Plc | Chemical process |
| GB8714707D0 (en) * | 1987-06-23 | 1987-07-29 | Beecham Group Plc | Chemical process |
-
1999
- 1999-10-20 GB GBGB9924855.1A patent/GB9924855D0/en not_active Ceased
-
2000
- 2000-10-20 AU AU10379/01A patent/AU1037901A/en not_active Abandoned
- 2000-10-20 WO PCT/GB2000/004060 patent/WO2001029031A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001029031A1 (en) | 2001-04-26 |
| AU1037901A (en) | 2001-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9917851D0 (en) | Process | |
| GB9922830D0 (en) | Processes | |
| GB9905512D0 (en) | Process | |
| GB9914209D0 (en) | Process | |
| GB9920917D0 (en) | Novel process | |
| GB9908814D0 (en) | Process | |
| GB9924855D0 (en) | Novel processes | |
| GB9924882D0 (en) | Novel process | |
| GB9914583D0 (en) | Novel process | |
| EP1242378A4 (en) | Novel processes | |
| GB9926908D0 (en) | Novel process | |
| GB9916392D0 (en) | Novel process | |
| GB9905418D0 (en) | Process | |
| GB9920147D0 (en) | Novel process | |
| GB9916187D0 (en) | Novel process | |
| GB9903087D0 (en) | Process | |
| GB9915303D0 (en) | Novel process | |
| GB9923539D0 (en) | Novel process | |
| GB9919001D0 (en) | Novel process | |
| GB9920146D0 (en) | Novel process | |
| GB9921243D0 (en) | Novel process | |
| GB9920937D0 (en) | Process | |
| GB9909973D0 (en) | Process | |
| GB9911181D0 (en) | Process | |
| GB9912319D0 (en) | Novel compounnds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |